Prot# IM103045: Evaluation of Belatacept as First-Line Immunosuppression in De Novo Liver Transplant Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date9/2/08 → 9/2/11

Funding

  • Bristol-Myers Squibb Company (IM103-045)